[1]
Abdulhalim J. A. Kinsara et al. 2020. Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Disease: Lessons and the Future. Internal Medicine. 4, 1 (Sep. 2020), 10–12. DOI:https://doi.org/10.17140/IMOJ-4-113.